Fig. 1From: Low-dose axitinib rechallenge with positive outcomes in a patient with metastatic renal cell carcinoma refractory to interferon α, sunitinib, axitinib, and nivolumab therapies: a case reportPathological findings of original right renal tumor. Pathological diagnosis is clear cell carcinomaBack to article page